Buolamwini J K, Knaus E E
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
Drug Des Deliv. 1990 Dec;7(1):19-31.
The synthesis and antinociceptive activity of 4-pyridylpiperdines (7 and 10) in which the phenyl group pf meperidine (1) or ketobemidone (3) is replaced by 2'-, 3'- or 4'-pyridyl is described. All were active in a rat writhing test, and the results showed that the point of attachment of the pyridyl ring to the 4-position was an important determinant of the activity; the relative potency order was 3'-pyridyl greater than 4'-pyridyl greater than 2'-pyridyl in each of the two series. The most potent compound (half the potency of meperidine) was 4-ethoxycarbonyl-4-(3'-pyridyl)-l-methylpiperidine (7b). This compound, and the corresponding 4'-isomer (7c), were further elaborated to provide 1'-phenyl, 1',6'-dihydropyridine (11), and 1'-phenyl, methyl or n-butyl. 1',2'-dihydropyridine (12) analogues containing an acyl function on the ring nitrogen. The most active compound in this series was 4-[4'-(1'-phenoxycarbonyl-2'-n-butyl-l',2'-dihydropyridyl)]- 4- ethoxycarbonyl-l-methylpiperdine (12k). Though less potent than the parent pyridyl compound (7c), it induced 70% inhibition in the writhing test at a dose of 8 mg/kg sc. [The ED50 for meperidine was 0.6 mg/kg sc.]
本文描述了4-吡啶基哌啶(7和10)的合成及其抗伤害感受活性,其中哌替啶(1)或酮苄吗啡(3)的苯基被2'-、3'-或4'-吡啶基取代。所有化合物在大鼠扭体试验中均有活性,结果表明吡啶环连接到4-位的位置是活性的重要决定因素;在两个系列中,相对效价顺序均为3'-吡啶基大于4'-吡啶基大于2'-吡啶基。最有效的化合物(效价为哌替啶的一半)是4-乙氧羰基-4-(3'-吡啶基)-1-甲基哌啶(7b)。该化合物以及相应的4'-异构体(7c)被进一步衍生,以提供1'-苯基、1',6'-二氢吡啶(11),以及在环氮上含有酰基官能团的1'-苯基、甲基或正丁基、1',2'-二氢吡啶(12)类似物。该系列中最具活性的化合物是4-[4'-(1'-苯氧羰基-2'-正丁基-1',2'-二氢吡啶基)]-4-乙氧羰基-1-甲基哌啶(12k)。虽然其效价比母体吡啶基化合物(7c)低,但在8mg/kg皮下注射剂量下,它在扭体试验中可诱导70%的抑制率。[哌替啶的ED50为0.6mg/kg皮下注射。]